Nov 03, 2023

intoDNA exhibits at SITC 2023, the premier cancer immunotherapy conference

KRAKÓW, POLAND, 1 November 2023 – intoDNA will be participating in the
Society for Immunotherapy of Cancer (SITC)’s 38th Annual Meeting in San Diego, CA.

Come and visit us in booth #1131 and let’s talk about how STRIDE assays can help
you accelerate your immunooncology research!

Learn more about SITC here!

For more information, please follow Us on:
Linkedin
For media inquiries, please contact:

See other articles

Jul 11, 2023

intoDNA to participate in the 2nd Annual Targeted Radiopharmaceuticals Summit US (TRP)

Keep Reading
Nov 17, 2023

STRIDE validated in human in vivo samples in collaboration with AstraZeneca

Keep Reading
Dec 20, 2021

intoDNA awarded funding from the Polish Agency for Enterprise Development

Keep Reading